This product includes the webinar and SAM credit


Description:

The goals of the Association for Molecular Pathology Pharmacogenomics (PGx) Working Group of the Association for Molecular Pathology Clinical Practice Committee are to define the key attributes of PGx alleles recommended for clinical testing and a minimum set of variants that should be included in clinical PGx genotyping assays. The CYP2C9 project and manuscript provides recommendations for a minimum panel of variant alleles (Tier 1) and an extended panel of variant alleles (Tier 2) that will aid clinical laboratories when designing assays for CYP2C9 testing.


Practice Guideline Available Here

Speaker: Stuart A. Scott, PhD, FACMG

Moderator: Yuan Ji, PhD, FACMG

Duration: 1 hr

Level of Instruction: Basic

Last day to purchase course and claim credit: March 20, 2020

Maximum SAM credit available: 1.0


How to claim credit: To earn SAM credit, all learners must watch the webinar, achieve a minimum score of 80% on the online quiz, and complete an online survey. To access the quiz, click "Submit credit" on the course homepage or click on "My Credit" on the menu to the left and then "submit credit" for the appropriate course.

This course is approved by the American Board of Pathology for 1.0 SAM credits.Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must successfully complete the online modular exams (answering at least 80% of the questions in a topic module correctly).

* You may not submit SAMs and CME/CMLE credit for the same content.


You may also be interested in:

 

Note: Join the AMP Family to purchase this content for a deep discount!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

 

Course Information
Course Date:
September 05, 2019
Course Objectives
  • To review CYP2C9 pharmacogenetics and highlight clinically relevant medications that are metabolized by CYP2C9.
  • To identify sequence variants that define CYP2C9 star (*) allele haplotypes.
  • To describe the AMP PGx Working Group and examine the reported CYP2C9 ‘Tier 1 and 2’ recommended alleles.
Recommendations for Clinical CYP2C9 Genotyping Allele Selection: A Joint Recommendation of the Association for Molecular Pathology and College of American Pathologists (+SAM)
Individual topic purchase: Selected
American Board of Pathology
Self-Assessment Module: 1.00
Products
Scott (+SAM)
AMP Regular Member: $10.00
AMP Technologist Member: $10.00
AMP Associate Member: $10.00
Non-member Price: $215.00